Improving Cancer Survival Prediction: A New Approach with EpiVax [...] | Comunicati stampa CataniaOggi
Pr-newswirePROVIDENCE, R.I., May 13, 2021 /PRNewswire/ -- EpiVax Therapeutics, Inc. (EVT) announces the publication [...]
Source: cataniaoggi.it
![Improving Cancer Survival Prediction: A New Approach with EpiVax [...] | Comunicati stampa CataniaOggi - Vimarsana News](https://www.cataniaoggi.it/img/logo_social.jpg){kind=logo}
Randy Sweis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Randy Sweis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Randy Sweis Today - Breaking & Trending Today
Improving Cancer Survival Prediction: A New Approach with EpiVax Therapeutics' Ancer Platform
Share this article Share this article Scientific Reports. This study demonstrates a superior method of survival analysis for cancer patients using EVT's Ancer platform. EVT spun-off from EpiVax, Inc. in 2017 to apply EpiVax tools to clinical research. Built on validated in silico tools EpiMatrix and JanusMatrix, Ancer analyzes individual cancer mutanomes to define the presence of T cell epitopes likely to be immunogenic. The concept behind Ancer is that the presence of a mutation alone is not sufficient to generate a protective immune response, but that the differences present between the n...
Source: prnewswire.com